{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:31:05Z","timestamp":1758990665696},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T00:00:00Z","timestamp":1327536000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0030746","type":"journal-article","created":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T21:51:53Z","timestamp":1327614713000},"page":"e30746","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Leishmania donovani: Immunostimulatory Cellular Responses of Membrane and Soluble Protein Fractions of Splenic Amastigotes in Cured Patient and Hamsters"],"prefix":"10.1371","volume":"7","author":[{"given":"Shraddha","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pragya","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rati","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Samant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Dube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,1,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.","volume":"2","author":"PJ Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrmicro981","article-title":"Leishmaniasis.","volume":"2","author":"P Desjeux","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1016\/j.vaccine.2007.05.042","article-title":"Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.","volume":"25","author":"S Bhowmick","year":"2007","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis.","volume":"70","author":"RN Coler","year":"2002","journal-title":"Infect Immun"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.1128\/IAI.73.12.8322-8333.2005","article-title":"Leishmania pifanoi amastigotes avoid macrophage production of superoxide by inducing heme degradation.","volume":"73","author":"NK Pham","year":"2005","journal-title":"Infect Immun"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1286-4579(02)01624-6","article-title":"Functional aspects of the Leishmania donovani lipophosphoglycan during macrophage infection.","volume":"4","author":"A Descoteaux","year":"2002","journal-title":"Microbes Infect"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.vaccine.2004.06.054","article-title":"Isolation of integral membrane proteins of Leishmania promastigotes and evaluation of their prophylactic potential in hamsters against experimental visceral leishmaniasis.","volume":"23","author":"R Garg","year":"2005","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1128\/IAI.70.12.6697-6706.2002","article-title":"Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB\/c mice.","volume":"70","author":"F Afrin","year":"2002","journal-title":"Infect Immun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0952-7915(93)90033-O","article-title":"T-cell and cytokine responses in leishmaniasis.","volume":"5","author":"SG Reed","year":"1993","journal-title":"Curr Opin Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1084\/jem.185.5.867","article-title":"Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model.","volume":"185","author":"HW Murray","year":"1997","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.4049\/jimmunol.161.11.6171","article-title":"LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.","volume":"161","author":"YA Skeiky","year":"1998","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.4049\/jimmunol.150.10.4713","article-title":"Mapping human T cell epitopes in Leishmania gp63: identification of cross-reactive and species-specific epitopes.","volume":"150","author":"DM Russo","year":"1993","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2005.12.053","article-title":"Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.","volume":"24","author":"R Garg","year":"2006","journal-title":"Vaccine"},{"key":"ref14","first-page":"439","article-title":"Animal models for vaccine studies for visceral leishmaniasis.","volume":"123","author":"R Garg","year":"2006","journal-title":"Indian J Med Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1574-6968.1993.tb06003.x","article-title":"Characterization of developmentally-regulated nucleases in promastigotes and amastigotes of Leishmania mexicana.","volume":"107","author":"PA Bates","year":"1993","journal-title":"FEMS Microbiol Lett"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1550-7408.1989.tb01086.x","article-title":"Extracellular cultivation and morphological characterization of amastigote-like forms of Leishmania panamensis and L. braziliensis.","volume":"36","author":"S Eperon","year":"1989","journal-title":"J Protozool"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0014-4894(84)90022-5","article-title":"Leishmania mexicana: serial cultivation of intracellular stages in a cell-free medium.","volume":"58","author":"AA Pan","year":"1984","journal-title":"Exp Parasitol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0020-7519(01)00259-4","article-title":"Life in vacuoles\u2013nutrient acquisition by Leishmania amastigotes.","volume":"31","author":"RJ Burchmore","year":"2001","journal-title":"Int J Parasitol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molbiopara.2008.12.012","article-title":"Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum.","volume":"165","author":"A Rochette","year":"2009","journal-title":"Mol Biochem Parasitol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2005.02745.x","article-title":"Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani.","volume":"140","author":"R Garg","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.7403880","article-title":"Human cutaneous lieshmania in a mouse macrophage line: propagation and isolation of intracellular parasites.","volume":"209","author":"KP Chang","year":"1980","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4.","volume":"227","author":"UK Laemmli","year":"1970","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.","volume":"76","author":"H Towbin","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/0006-2952(87)90508-9","article-title":"Effects of methotrexate and other antifolates on the growth and dihydrofolate reductase activity of Leishmania promastigotes.","volume":"36","author":"DA Scott","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0035-9203(90)90319-A","article-title":"Enzyme-linked immunosorbent assay in the diagnosis of kala-azar in Bhadohi (Varanasi), India.","volume":"84","author":"A Choudhry","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/elps.1150190539","article-title":"Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis.","volume":"19","author":"MP Molloy","year":"1998","journal-title":"Electrophoresis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1002\/1522-2683(20001001)21:16<3329::AID-ELPS3329>3.0.CO;2-F","article-title":"Membrane proteomics: use of additive main effects with multiplicative interaction model to classify plasma membrane proteins according to their solubility and electrophoretic properties.","volume":"21","author":"V Santoni","year":"2000","journal-title":"Electrophoresis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.","volume":"141","author":"AH Ding","year":"1988","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1017\/S0031182007002569","article-title":"Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.","volume":"134","author":"M Samant","year":"2007","journal-title":"Parasitology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0166-6851(91)90102-C","article-title":"An antigenically distinct lipophosphoglycan on amastigotes of Leishmania major.","volume":"45","author":"TA Glaser","year":"1991","journal-title":"Mol Biochem Parasitol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"17081","DOI":"10.1074\/jbc.271.29.17081","article-title":"The developmental expression of Leishmania donovani A2 amastigote-specific genes is post-transcriptionally mediated and involves elements located in the 3\u2032-untranslated region.","volume":"271","author":"H Charest","year":"1996","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1016\/j.vaccine.2008.06.102","article-title":"Induction of Th1-type cellular responses in cured\/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa.","volume":"26","author":"S Kumari","year":"2008","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.","volume":"356","author":"EA Khalil","year":"2000","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.4049\/jimmunol.142.12.4441","article-title":"Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen\/liposomes. Optimization and assessment of the requirement for intravenous immunization.","volume":"142","author":"LP Kahl","year":"1989","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.7904381","article-title":"The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.","volume":"263","author":"LC Afonso","year":"1994","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1128\/IAI.56.12.3272-3279.1988","article-title":"Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.","volume":"56","author":"J Champsi","year":"1988","journal-title":"Infect Immun"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.144.2.699","article-title":"Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.","volume":"144","author":"CL Jaffe","year":"1990","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/infdis\/161.6.1313","article-title":"Prophylactic immunization against experimental Leishmania donovani infection by use of a purified protein vaccine.","volume":"161","author":"AC White Jr","year":"1990","journal-title":"J Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/clinids\/13.5.1009","article-title":"Experimental leishmaniasis in humans: review.","volume":"13","author":"PC Melby","year":"1991","journal-title":"Rev Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective Leishmania antigen.","volume":"268","author":"E Mougneau","year":"1995","journal-title":"Science"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0169-4758(97)01164-2","article-title":"Leishmania amastigote target antigens: the challenge of a stealthy intracellular parasite.","volume":"14","author":"D McMahon-Pratt","year":"1998","journal-title":"Parasitol Today"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.90.24.11473","article-title":"Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63.","volume":"90","author":"ND Connell","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0001-706X(94)90028-0","article-title":"Evaluation of recombinant gp63, the major Leishmania surface glycoprotein, as a diagnostic molecule for leishmaniasis in vervet monkeys.","volume":"58","author":"MM Gicheru","year":"1994","journal-title":"Acta Trop"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development.","volume":"14","author":"E Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2567.2006.02468.x","article-title":"Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies.","volume":"119","author":"R Silvestre","year":"2006","journal-title":"Immunology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2567.2007.02725.x","article-title":"A Leishmania infantum cytosolic tryparedoxin activates B cells to secrete interleukin-10 and specific immunoglobulin.","volume":"123","author":"SM Cabral","year":"2008","journal-title":"Immunology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.iy.13.040195.001343","article-title":"Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. .","volume":"13","author":"G Trinchieri","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.177.6.1797","article-title":"Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.","volume":"177","author":"JP Sypek","year":"1993","journal-title":"J Exp Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.4049\/jimmunol.154.9.4623","article-title":"IL-12 enhances Th1-type responses in human Leishmania donovani infections.","volume":"154","author":"HW Ghalib","year":"1995","journal-title":"J Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1172\/JCI26469","article-title":"Parasite genome similarities offer hope for new drugs and vaccines.","volume":"115","author":"S Bloom","year":"2005","journal-title":"J Clin Invest"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2249.2005.03000.x","article-title":"Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals.","volume":"143","author":"P Tripathi","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4269\/ajtmh.1992.46.123","article-title":"Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection.","volume":"46","author":"AC White Jr","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1590\/S0074-02761999000300015","article-title":"T cell response of asymptomatic Leishmania chagasi infected subjects to recombinant leishmania antigens.","volume":"94","author":"SR Costa","year":"1999","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1128\/IAI.57.10.2971-2976.1989","article-title":"Identification of antigens recognized by T cells in human leishmaniasis: analysis of T-cell clones by immunoblotting.","volume":"57","author":"PC Melby","year":"1989","journal-title":"Infect Immun"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/IAI.57.10.3091-3096.1989","article-title":"Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters.","volume":"57","author":"C Gifawesen","year":"1989","journal-title":"Infect Immun"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-3024.1992.tb00005.x","article-title":"Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens.","volume":"14","author":"V Rodrigues Junior","year":"1992","journal-title":"Parasite Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-2478(91)90024-5","article-title":"Role of cytokines in killing of intracellular pathogens.","volume":"30","author":"FY Liew","year":"1991","journal-title":"Immunol Lett"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/eji.1830240328","article-title":"Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major.","volume":"24","author":"J Assreuy","year":"1994","journal-title":"Eur J Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1126\/science.284.5416.951","article-title":"Requirement for type 2 NO synthase for IL-12 signaling in innate immunity.","volume":"284","author":"A Diefenbach","year":"1999","journal-title":"Science"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0030746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T02:00:46Z","timestamp":1686708046000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0030746"}},"subtitle":[],"editor":[{"given":"Ira","family":"Blader","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,26]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0030746","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,26]]}}}